GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (STU:2QG) » Definitions » Gross Profit

Quantum Genomics (STU:2QG) Gross Profit : €-28.90 Mil (TTM As of Dec. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Quantum Genomics Gross Profit?

Quantum Genomics's gross profit for the six months ended in Dec. 2022 was €-25.29 Mil. Quantum Genomics's gross profit for the trailing twelve months (TTM) ended in Dec. 2022 was €-28.90 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Quantum Genomics's gross profit for the six months ended in Dec. 2022 was €-25.29 Mil. Quantum Genomics's Revenue for the six months ended in Dec. 2022 was €-0.29 Mil. Therefore, Quantum Genomics's Gross Margin % for the quarter that ended in Dec. 2022 was 8,662.33%.

Quantum Genomics had a gross margin of 8,662.33% for the quarter that ended in Dec. 2022 => No sustainable competitive advantage


Quantum Genomics Gross Profit Historical Data

The historical data trend for Quantum Genomics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Gross Profit Chart

Quantum Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.70 -7.89 -12.10 -18.34 -28.90

Quantum Genomics Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.00 0.15 -18.49 -3.60 -25.29

Competitive Comparison of Quantum Genomics's Gross Profit

For the Biotechnology subindustry, Quantum Genomics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum Genomics's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum Genomics's Gross Profit distribution charts can be found below:

* The bar in red indicates where Quantum Genomics's Gross Profit falls into.



Quantum Genomics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Quantum Genomics's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=0.605 - 29.502
=-28.90

Quantum Genomics's Gross Profit for the quarter that ended in Dec. 2022 is calculated as

Gross Profit (Q: Dec. 2022 )=Revenue - Cost of Goods Sold
=-0.292 - 25.002
=-25.29

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-28.90 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Quantum Genomics's Gross Margin % for the quarter that ended in Dec. 2022 is calculated as

Gross Margin % (Q: Dec. 2022 )=Gross Profit (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=(Revenue - Cost of Goods Sold) / Revenue
=-25.29 / -0.292
=8,662.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Quantum Genomics  (STU:2QG) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Quantum Genomics had a gross margin of 8,662.33% for the quarter that ended in Dec. 2022 => No sustainable competitive advantage


Quantum Genomics Gross Profit Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Genomics (STU:2QG) Business Description

Traded in Other Exchanges
N/A
Address
33, Rue Marbeuf, Paris, FRA, 75008
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (STU:2QG) Headlines

No Headlines